Lung Cancer as a Subsequent Malignant Neoplasm in Survivors of Childhood Cancer

被引:2
作者
Ghosh, Taumoha [1 ]
Chen, Yan [2 ]
Dietz, Andrew C. [3 ]
Armstrong, Gregory T. [4 ]
Howell, Rebecca M. [5 ]
Smith, Susan A. [5 ]
Mulrooney, Daniel A. [4 ]
Turcotte, Lucie M. [6 ]
Yuan, Yan [2 ]
Yasui, Yutaka [4 ]
Neglia, Joseph P. [6 ]
机构
[1] Univ Miami, 1601 NW 12th Ave,MCCD 5032, Miami, FL 33136 USA
[2] Univ Alberta, Edmonton, AB, Canada
[3] Bluebird Bio Inc, Cambridge, MA USA
[4] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Univ Minnesota, Minneapolis, MN USA
关键词
LI-FRAUMENI SYNDROME; 5-YEAR SURVIVORS; RADIATION-THERAPY; HODGKINS-DISEASE; LATE MORTALITY; HIGH-RISK; RETINOBLASTOMA; CHEMOTHERAPY; RADIOTHERAPY; LYMPHOMA;
D O I
10.1158/1055-9965.EPI-21-0250
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Lung cancer, the most common cause of cancerrelated death in adults, has not been well studied as a subsequent assessed prevalence, risk factors, and outcomes for lung SMN in the Methods: Among 25,654 5-year survivors diagnosed with childhood cancer (<21 years), lung cancer was self-reported and confirmed by pathology record review. Standardized incidence ratios (SIR) and cumulative incidences were calculated, comparing survivors to the general population, and hazard ratios (HR) were estimated using Cox regression for diagnosis and treatment exposures. Results: Forty-two survivors developed a lung SMN [SIR, 4.0; 95% confidence interval (CI), 2.9-5.4] with a cumulative incidence of 0.16% at 30 years from diagnosis (95% CI, 0.09%-0.23%). In a treatment model, chest radiation doses of 10-30 Gy (HR, 3.4; 95% CI, 1.05-11.0), >30-40 Gy (HR, 4.6; 95% CI, 1.5-14.3), and>40 Gy (HR, 9.1; 95% CI, 3.1-27.0) were associated with lung SMN, with a monotone dose trend (Ptrend < 0.001). Survivors of Hodgkin lymphoma (SIR, 9.3; 95% CI, 6.2-13.4) and bone cancer (SIR, 4.4; 95% CI, 1.8-9.1) were at greatest risk for lung SMN. Conclusions: Survivors of childhood cancer are at increased risk for lung cancer compared with the general population. Greatest risk was observed among survivors who received chest radiotherapy or with primary diagnoses of Hodgkin lymphoma or bone cancer. Impact: This study describes the largest number of observed lung cancers in childhood cancer survivors and elucidates need for further study in this aging and growing population.
引用
收藏
页码:2235 / 2243
页数:9
相关论文
共 43 条
  • [1] Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
    Aberle, Denise R.
    Adams, Amanda M.
    Berg, Christine D.
    Black, William C.
    Clapp, Jonathan D.
    Fagerstrom, Richard M.
    Gareen, Ilana F.
    Gatsonis, Constantine
    Marcus, Pamela M.
    Sicks, JoRean D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) : 395 - 409
  • [2] Late Mortality Among 5-Year Survivors of Childhood Cancer: A Summary From the Childhood Cancer Survivor Study
    Armstrong, Gregory T.
    Liu, Qi
    Yasui, Yutaka
    Neglia, Joseph P.
    Leisenring, Wendy
    Robison, Leslie L.
    Mertens, Ann C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (14) : 2328 - 2338
  • [3] High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the late effects study group
    Bhatia, S
    Yasui, Y
    Robison, LL
    Birch, JM
    Bogue, MK
    Diller, L
    DeLaat, C
    Fossati-Bellani, F
    Morgan, E
    Oberlin, O
    Reaman, G
    Ruymann, FB
    Tersak, J
    Meadows, AT
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 4386 - 4394
  • [4] Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
    Bougeard, Gaelle
    Renaux-Petel, Mariette
    Flaman, Jean-Michel
    Charbonnier, Camille
    Fermey, Pierre
    Belotti, Muriel
    Gauthier-Villars, Marion
    Stoppa-Lyonnet, Dominique
    Consolino, Emilie
    Brugieres, Laurence
    Caron, Olivier
    Benusiglio, Patrick R.
    Bressac-de Paillerets, Brigitte
    Bonadona, Valerie
    Bonaiti-Pellie, Catherine
    Tinat, Julie
    Baert-Desurmont, Stephanie
    Frebourg, Thierry
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (21) : 2345 - U33
  • [5] Lung Adenocarcinoma as Part of the Li-Fraumeni Syndrome Spectrum: Preliminary Data of the LIFSCREEN Randomized Clinical Trial
    Caron, Olivier
    Frebourg, Thierry
    Benusiglio, Patrick R.
    Foulon, Stephanie
    Brugieres, Laurence
    [J]. JAMA ONCOLOGY, 2017, 3 (12) : 1736 - 1737
  • [6] Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study
    Castellino, Sharon M.
    Geiger, Ann M.
    Mertens, Ann C.
    Leisenring, Wendy M.
    Tooze, Janet A.
    Goodman, Pam
    Stovall, Marilyn
    Robison, Leslie L.
    Hudson, Melissa M.
    [J]. BLOOD, 2011, 117 (06) : 1806 - 1816
  • [7] Lung Cancer Screening with Low-Dose Computed Tomography
    Chiles, Caroline
    [J]. RADIOLOGIC CLINICS OF NORTH AMERICA, 2014, 52 (01) : 27 - +
  • [8] Secondary malignancies in pediatric cancer survivors: Perspectives and review of the literature
    Choi, Daniel K.
    Helenowski, Irene
    Hijiya, Nobuko
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (08) : 1764 - 1773
  • [9] Effects of radiation therapy on the lung: Radiologic appearances and differential diagnosis
    Choi, YW
    Munden, RF
    Erasmus, JJ
    Park, KJ
    Chung, WK
    Chol Jeon, S
    Park, CK
    [J]. RADIOGRAPHICS, 2004, 24 (04) : 985 - 997
  • [10] Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity
    Feijen, Elizabeth A. M.
    Leisenring, Wendy M.
    Stratton, Kayla L.
    Ness, Kirsten K.
    van der Pal, Helena J. H.
    van Dalen, Elvira C.
    Armstrong, Gregory T.
    Aune, Gregory J.
    Green, Daniel M.
    Hudson, Melissa M.
    Loonen, Jacqueline
    Oeffinger, Kevin C.
    Robison, Leslie L.
    Yasui, Yutaka
    Kremer, Leontien C. M.
    Chow, Eric J.
    [J]. JAMA ONCOLOGY, 2019, 5 (06) : 864 - 871